Antoine Anfray Selected Research

Antoine Anfray Research Topics

3	Cognitive Dysfunction 12/2023 - 10/2020
3	Alzheimer Disease (Alzheimer's Disease) 08/2023 - 01/2020
3	Stroke (Strokes) 01/2021 - 01/2018
2	Ischemic Stroke 01/2021 - 01/2021
1	Hypertension (High Blood Pressure) 12/2023
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 10/2020
1	Amyloid Plaque 10/2020
1	Hyperemia 10/2020
1	Tauopathies 01/2020
1	Frontotemporal Dementia (Semantic Dementia) 01/2020
1	Atherosclerosis 01/2018
1	Inflammation (Inflammations) 01/2018

3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 10/2020
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2020 - 01/2020
1	CytokinesIBA 12/2023
1	InterleukinsIBA 12/2023
1	SaltsIBA 12/2023
1	Interleukin-17 (Interleukin 17)IBA 12/2023
1	Apolipoprotein E4IBA 08/2023
1	U 0126 (UO 126)IBA 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 01/2021
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	Peptides (Polypeptides)IBA 10/2020
1	Amyloid (Amyloid Fibrils)IBA 10/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2020
1	peptide AIBA 10/2020
1	Plasminogen Activator Inhibitor 1IBA 10/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	CC ChemokinesIBA 01/2018
1	LigandsIBA 01/2018
1	AlarminsIBA 01/2018

1	Therapeutics 01/2021
1	Thrombectomy 01/2021